InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,048.27
(
0.28%
)
Post# of 252588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MotionMan

Send PM Follow Ignore
Followers 0
Posts 348
Boards Moderated 0
Alias Born 06/10/2009

MotionMan

Re: DewDiligence post# 84500

Sunday, 10/04/2009 9:09:15 PM

Sunday, October 04, 2009 9:09:15 PM

Post# of 252588
MNTA: Dew, do you think MNTA's recent cash infusion may be an indication that they think FDA response on generic Lovenox will be further out than they thought? The management team cannot be that in the dark regarding FDA response. Or is it a case of "do it, when you can" mentality.
Is there any information regarding Teva's and Amphastar's ANDA's? I can't find anything out there. I don't know how one can gauge the extent of their ability to characterize Lovenox.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up